QTRX | Quanterix Corporation Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	6.17 - 6.58
52 Week Range	6.16 - 23.86
Beta	1.07
Implied Volatility	347.77%
IV Rank	114.87%
Day's Volume	455,613
Average Volume	817,981
Shares Outstanding	38,776,200
Market Cap	252,433,062
Sector	Healthcare
Industry	Medical - Devices
IPO Date	2017-12-07

Valuation
Profitability
Growth
Health
P/E Ratio	-6.51
Forward P/E Ratio	-19.41
EPS	-1.00
1YR Price Target	22.50
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	441
Country	USA
Website	QTRX

Quanterix Corp is a life sciences company. It focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum and other fluids which are undetectable using conventional, analog immunoassay technologies. The company has developed Simoa technology which is a method of detection of proteins and has the capability of analyzing nearly six biomarkers per test, with anticipated expansion capability.

QTRX's peers: BBLG, HSCS, TIVC, VVOS, TLIS, KIDS, OFIX, SGHT, NPCE, CVRX, PRCT, LUNG, MXCT, CTKB, HSKA, ELMD, SIBN, RPID, TCMD

*Chart delayed

Analyzing fundamentals for QTRX we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is desperately bad and Health is passable. For more detailed analysis please see QTRX Fundamentals page.

Watching at QTRX technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on QTRX Technicals page.